Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
fda
life sciences
national blog main
san diego blog main
san diego top stories
alder biopharmaceuticals
amgen
bial
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
david rind
detroit blog main
detroit top stories
digital therapeutics
drug development
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
health
indiana blog main
indiana top stories
institute for clinical and economic review
medical devices
migraine research foundation
migraines
national
national top stories
neurocrine
neurodegeneration
neuroscience
What
fda
3
×
gets
3
×
new
nod
patients
add
amgen
app
approval
based
biofourmis
boston
breakthrough
called
candidates
carbidopa
class
closer
combination
company
control
daily
designation
developed
device
digital
disease
drug
experience
failure
founded
founder
future
goal
head
heart
home
imagining
kuldeep
levodopa
Language
unset
Current search:
fda
×
gets
×
biotech
×
@techcrunch.com
2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
